Vault-13

683 Capital Management, LLC

NEW YORK, NY · CIK 1404574 · 13F filing filed 2025-08-14

SEC-registered investment adviser since 2012 · limited liability company

As an employer

$986.1m reported value +0.0% vs Q1 2025
116positions
37.5%in top 10
18 new 32 added 47 reduced 21 sold out vs Q1 2025

Options: 1 call positions ($369.1k notional), 17 put positions ($535.9m notional) – listed below, not included above.

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CAPITAL ONE FINL CORP COM COF COF 321,500 $68.4m6.94% 6.94% AddedShares held: Q3 2024 335.0k, Q4 2024 320.0k, Q1 2025 308.0k, Q2 2025 321.5k +13.5k +13,500 4.4%
2 CARVANA CO CL A CVNA CVNA 155,000 $52.2m5.30% 5.30% ReducedShares held: Q3 2024 225.0k, Q4 2024 225.0k, Q1 2025 172.0k, Q2 2025 155.0k -17.0k -17,000 -9.9%
3 GXO LOGISTICS INCORPORATED COMMON STOCK GXO GXO 940,000 $45.8m4.64% 4.64% ReducedShares held: Q3 2024 350.0k, Q4 2024 650.0k, Q1 2025 950.0k, Q2 2025 940.0k -10.0k -10,000 -1.1%
4 AMENTUM HOLDINGS INC COM AMTM AMTM 1,630,000 $38.5m3.90% 3.90% AddedShares held: Q3 2024 0, Q4 2024 425.0k, Q1 2025 1.0m, Q2 2025 1.6m +617.0k +617,000 60.9%
5 HILTON GRAND VACATIONS INC COM HGV HGV 775,000 $32.2m3.26% 3.26% AddedShares held: Q3 2024 1.2m, Q4 2024 950.0k, Q1 2025 766.0k, Q2 2025 775.0k +9.0k +9,000 1.2%
6 BRIDGEBIO PHARMA INC NOTE 2.500% 3/1 · principal BBIO 2.5 03.15.27 · principal BBIO 2.5 03.15.27 24,750,000 $30.8m3.13% 3.13% UnchangedPrincipal held: Q3 2024 23.2m, Q4 2024 24.8m, Q1 2025 24.8m, Q2 2025 24.8m
7 BARRICK MNG CORP COM SHS B B 1,375,000 $28.6m2.90% 2.90% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.4m
8 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 4,100,000 $26.7m2.70% 2.70% AddedShares held: Q3 2024 4.2m, Q4 2024 3.8m, Q1 2025 3.9m, Q2 2025 4.1m +175.0k +175,000 4.5%
9 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 445,000 $24.6m2.49% 2.49% ReducedShares held: Q3 2024 420.0k, Q4 2024 410.0k, Q1 2025 500.0k, Q2 2025 445.0k -55.0k -55,000 -11.0%
10 WESTERN DIGITAL CORP COM WDC WDC 339,000 $21.7m2.20% 2.20% ReducedShares held: Q3 2024 0, Q4 2024 439.4k, Q1 2025 500.0k, Q2 2025 339.0k -161.0k -161,000 -32.2%
11 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 2,105,000 $20.2m2.05% 2.05% AddedShares held: Q3 2024 1.0m, Q4 2024 1.0m, Q1 2025 1.4m, Q2 2025 2.1m +660.0k +660,000 45.7%
12 UWM HOLDINGS CORPORATION COM CL A UWMC UWMC 4,800,000 $19.9m2.02% 2.02% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 4.8m
13 BRIDGEBIO PHARMA INC COM BBIO BBIO 425,000 $18.4m1.86% 1.86% ReducedShares held: Q3 2024 550.0k, Q4 2024 635.0k, Q1 2025 575.0k, Q2 2025 425.0k -150.0k -150,000 -26.1%
14 UNIQURE NV SHS QURE QURE 1,285,000 $17.9m1.82% 1.82% ReducedShares held: Q3 2024 1.9m, Q4 2024 1.5m, Q1 2025 1.6m, Q2 2025 1.3m -265.0k -265,000 -17.1%
15 ERO COPPER CORP COM ERO ERO 1,050,000 $17.7m1.80% 1.80% ReducedShares held: Q3 2024 2.0m, Q4 2024 2.5m, Q1 2025 1.8m, Q2 2025 1.1m -750.5k -750,480 -41.7%
16 MEIRAGTX HLDGS PLC COM MGTX MGTX 2,690,000 $17.5m1.78% 1.78% AddedShares held: Q3 2024 2.5m, Q4 2024 2.4m, Q1 2025 2.6m, Q2 2025 2.7m +115.0k +115,000 4.5%
17 UNITEDHEALTH GROUP INC COM UNH UNH 55,500 $17.3m1.76% 1.76% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 52.0k, Q2 2025 55.5k +3.5k +3,500 6.7%
18 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 2,160,000 $13.8m1.40% 1.40% ReducedShares held: Q3 2024 2.0m, Q4 2024 1.9m, Q1 2025 2.4m, Q2 2025 2.2m -251.4k -251,400 -10.4%
19 ELI LILLY & CO COM LLY LLY 17,750 $13.8m1.40% 1.40% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 7.5k, Q2 2025 17.8k +10.2k +10,250 136.7%
20 COGENT COMMUNICATIONS HLDGS COM NEW CCOI CCOI 280,000 $13.5m1.37% 1.37% ReducedShares held: Q3 2024 380.0k, Q4 2024 300.0k, Q1 2025 295.0k, Q2 2025 280.0k -15.0k -15,000 -5.1%
21 IRSA INVERSIONES Y REP S A SPON GDS ECH 10 IRS IRS 905,000 $12.6m1.28% 1.28% AddedShares held: Q3 2024 1.1m, Q4 2024 400.0k, Q1 2025 501.0k, Q2 2025 905.0k +404.0k +404,000 80.6%
22 LENNAR CORP CL B LEN.B LEN.B 115,000 $12.1m1.23% 1.23% UnchangedShares held: Q3 2024 115.0k, Q4 2024 115.0k, Q1 2025 115.0k, Q2 2025 115.0k
23 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 4,350,000 $11.8m1.20% 1.20% ReducedShares held: Q3 2024 4.8m, Q4 2024 4.5m, Q1 2025 4.6m, Q2 2025 4.3m -285.0k -285,000 -6.2%
24 ASML HOLDING N V N Y REGISTRY SHS ASML ASML 14,650 $11.7m1.19% 1.19% ReducedShares held: Q3 2024 5.0k, Q4 2024 15.7k, Q1 2025 15.7k, Q2 2025 14.7k -1.0k -1,000 -6.4%
25 SAREPTA THERAPEUTICS INC COM SRPT SRPT 675,000 $11.5m1.17% 1.17% AddedShares held: Q3 2024 87.2k, Q4 2024 102.0k, Q1 2025 165.0k, Q2 2025 675.0k +510.0k +510,000 309.1%
26 XENIA HOTELS & RESORTS INC COM XHR XHR 890,000 $11.2m1.13% 1.13% UnchangedShares held: Q3 2024 1.3m, Q4 2024 1.0m, Q1 2025 890.0k, Q2 2025 890.0k
27 INSPIRED ENTMT INC COM INSE INSE 1,365,000 $11.2m1.13% 1.13% ReducedShares held: Q3 2024 1.8m, Q4 2024 1.7m, Q1 2025 1.6m, Q2 2025 1.4m -198.6k -198,552 -12.7%
28 ANAPTYSBIO INC COM ANAB ANAB 500,000 $11.1m1.13% 1.13% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 195.6k, Q2 2025 500.0k +304.4k +304,373 155.6%
29 SAGE THERAPEUTICS INC COM SAGE SAGE 1,150,000 $10.5m1.06% 1.06% AddedShares held: Q3 2024 600.0k, Q4 2024 630.0k, Q1 2025 1.0m, Q2 2025 1.1m +150.0k +150,000 15.0%
30 ARIS MNG CORP COM ARIS ARIS 1,500,000 $10.1m1.03% 1.03% ReducedShares held: Q3 2024 1.9m, Q4 2024 1.8m, Q1 2025 1.6m, Q2 2025 1.5m -125.0k -125,000 -7.7%
31 VIGIL NEUROSCIENCE INC COM VIGL VIGL 1,261,772 $10.0m1.02% 1.02% ReducedShares held: Q3 2024 1.2m, Q4 2024 1.4m, Q1 2025 1.7m, Q2 2025 1.3m -478.2k -478,228 -27.5%
32 KNOT OFFSHORE PARTNERS LP COM UNITS KNOP KNOP 1,585,000 $9.9m1.01% 1.01% ReducedShares held: Q3 2024 1.6m, Q4 2024 1.6m, Q1 2025 1.6m, Q2 2025 1.6m -25.0k -25,000 -1.6%
33 ZEVRA THERAPEUTICS INC COM NEW ZVRA ZVRA 1,125,000 $9.9m1.01% 1.01% ReducedShares held: Q3 2024 1.2m, Q4 2024 1.2m, Q1 2025 1.2m, Q2 2025 1.1m -100.8k -100,834 -8.2%
34 ELEVANCE HEALTH INC COM ELV ELV 25,000 $9.7m0.99% 0.99% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 27.0k, Q2 2025 25.0k -2.0k -2,000 -7.4%
35 CRESUD S A C I F Y A SPONSORED ADR CRESY CRESY 889,000 $9.6m0.97% 0.97% AddedShares held: Q3 2024 841.0k, Q4 2024 885.0k, Q1 2025 830.0k, Q2 2025 889.0k +59.0k +59,000 7.1%
36 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 302,000 $9.5m0.97% 0.97% AddedShares held: Q3 2024 300.0k, Q4 2024 300.0k, Q1 2025 300.0k, Q2 2025 302.0k +2.0k +2,000 0.7%
37 STRATEGY INC NOTE 0.875% 3/1 · principal MSTR 0.875 03.15.31 · principal MSTR 0.875 03.15.31 5,000,000 $9.4m0.95% 0.95% UnchangedPrincipal held: Q3 2024 0, Q4 2024 0, Q1 2025 5.0m, Q2 2025 5.0m
38 CENTENE CORP DEL COM CNC CNC 170,000 $9.2m0.94% 0.94% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 265.0k, Q2 2025 170.0k -95.0k -95,000 -35.9%
39 WESTERN ALLIANCE BANCORP COM WAL WAL 117,500 $9.2m0.93% 0.93% AddedShares held: Q3 2024 100.0k, Q4 2024 100.0k, Q1 2025 110.0k, Q2 2025 117.5k +7.5k +7,500 6.8%
40 LENNAR CORP CL A LEN LEN 79,000 $8.7m0.89% 0.89% AddedShares held: Q3 2024 0, Q4 2024 7.5k, Q1 2025 35.0k, Q2 2025 79.0k +44.0k +44,000 125.7%
41 MILLROSE PPTYS INC COM CL A MRP MRP 303,800 $8.7m0.88% 0.88% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 355.0k, Q2 2025 303.8k -51.2k -51,200 -14.4%
42 GOSSAMER BIO INC COM GOSS GOSS 6,340,000 $7.8m0.79% 0.79% AddedShares held: Q3 2024 5.8m, Q4 2024 7.0m, Q1 2025 6.1m, Q2 2025 6.3m +240.0k +240,000 3.9%
43 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 24,865 $7.5m0.76% 0.76% AddedShares held: Q3 2024 0, Q4 2024 1.0k, Q1 2025 23.6k, Q2 2025 24.9k +1.3k +1,289 5.5%
44 APELLIS PHARMACEUTICALS INC COM APLS APLS 410,000 $7.1m0.72% 0.72% AddedShares held: Q3 2024 235.0k, Q4 2024 360.0k, Q1 2025 333.0k, Q2 2025 410.0k +77.0k +77,000 23.1%
45 SHARKNINJA INC COM SHS SN SN 70,000 $6.9m0.70% 0.70% NewShares held: Q3 2024 180.0k, Q4 2024 0, Q1 2025 0, Q2 2025 70.0k
46 GOSSAMER BIO INC NOTE 5.000% 6/0 · principal GOSS 5 06.01.27 · principal GOSS 5 06.01.27 13,145,000 $6.8m0.69% 0.69% UnchangedPrincipal held: Q3 2024 12.1m, Q4 2024 12.1m, Q1 2025 13.1m, Q2 2025 13.1m
47 VIKING THERAPEUTICS INC COM VKTX VKTX 254,000 $6.7m0.68% 0.68% ReducedShares held: Q3 2024 320.0k, Q4 2024 280.0k, Q1 2025 305.0k, Q2 2025 254.0k -51.0k -51,000 -16.7%
48 ALPHABET INC CAP STK CL A GOOGL GOOGL 36,000 $6.3m0.64% 0.64% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 36.0k
49 SCIENCE APPLICATIONS INTL CO COM SAIC SAIC 55,500 $6.2m0.63% 0.63% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 49.0k, Q2 2025 55.5k +6.5k +6,500 13.3%
50 CARDLYTICS INC NOTE 4.250% 4/0 · principal CDLX 4.25 04.01.29 · principal CDLX 4.25 04.01.29 15,000,000 $6.2m0.62% 0.62% NewPrincipal held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 15.0m
51 AMAZON COM INC COM AMZN AMZN 28,000 $6.1m0.62% 0.62% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 28.0k
52 SANDISK CORP COM SNDK SNDK 132,000 $6.0m0.61% 0.61% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 140.0k, Q2 2025 132.0k -8.0k -8,000 -5.7%
53 BARNES & NOBLE ED INC COM NEW BNED BNED 487,000 $5.7m0.58% 0.58% ReducedShares held: Q3 2024 100.0k, Q4 2024 350.0k, Q1 2025 515.0k, Q2 2025 487.0k -28.0k -28,000 -5.4%
54 CAESARS ENTERTAINMENT INC NE COM CZR CZR 200,000 $5.7m0.58% 0.58% ReducedShares held: Q3 2024 250.0k, Q4 2024 301.9k, Q1 2025 375.0k, Q2 2025 200.0k -175.0k -175,000 -46.7%
55 SEADRILL LTD COM SDRL SDRL 215,000 $5.6m0.57% 0.57% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 60.0k, Q2 2025 215.0k +155.0k +155,000 258.3%
56 PATRIA INVESTMENTS LIMITED COM CL A PAX PAX 400,000 $5.6m0.57% 0.57% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 400.0k
57 AMICUS THERAPEUTICS INC COM FOLD FOLD 960,000 $5.5m0.56% 0.56% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 275.0k, Q2 2025 960.0k +685.0k +685,000 249.1%
58 PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS FRNM FRNM 500,000 $5.3m0.54% 0.54% UnchangedShares held: Q3 2024 500.0k, Q4 2024 500.0k, Q1 2025 500.0k, Q2 2025 500.0k
59 CACI INTL INC CL A CACI CACI 11,000 $5.2m0.53% 0.53% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 11.5k, Q2 2025 11.0k -500 -500 -4.3%
60 WILLOW LANE ACQUISITION CORP ORD SHS CL A WLAC WLAC 500,000 $5.1m0.52% 0.52% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 500.0k, Q2 2025 500.0k
61 SABLE OFFSHORE CORP COM SHS SOC SOC 225,000 $4.9m0.50% 0.50% AddedShares held: Q3 2024 24.1k, Q4 2024 0, Q1 2025 130.5k, Q2 2025 225.0k +94.5k +94,500 72.4%
62 BRITISH AMERN TOB PLC SPONSORED ADR BTI BTI 100,000 $4.7m0.48% 0.48% UnchangedShares held: Q3 2024 100.0k, Q4 2024 100.0k, Q1 2025 100.0k, Q2 2025 100.0k
63 BUILDERS FIRSTSOURCE INC COM BLDR BLDR 38,000 $4.4m0.45% 0.45% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 38.0k
64 GERON CORP COM GERN GERN 3,100,000 $4.4m0.44% 0.44% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 2.9m, Q2 2025 3.1m +250.0k +250,000 8.8%
65 STAGWELL INC COM CL A STGW STGW 950,000 $4.3m0.43% 0.43% AddedShares held: Q3 2024 385.0k, Q4 2024 750.0k, Q1 2025 750.0k, Q2 2025 950.0k +200.0k +200,000 26.7%
66 ABEONA THERAPEUTICS INC COM NEW ABEO ABEO 750,000 $4.3m0.43% 0.43% AddedShares held: Q3 2024 675.0k, Q4 2024 791.8k, Q1 2025 675.0k, Q2 2025 750.0k +75.0k +75,000 11.1%
67 CITIGROUP INC COM NEW C C 50,000 $4.3m0.43% 0.43% NewShares held: Q3 2024 200.0k, Q4 2024 200.0k, Q1 2025 0, Q2 2025 50.0k
68 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 1,080,000 $4.1m0.42% 0.42% AddedShares held: Q3 2024 0, Q4 2024 290.0k, Q1 2025 476.0k, Q2 2025 1.1m +604.0k +604,000 126.9%
69 STAR BULK CARRIERS CORP. SHS PAR SBLK SBLK 225,000 $3.9m0.39% 0.39% ReducedShares held: Q3 2024 360.0k, Q4 2024 0, Q1 2025 300.0k, Q2 2025 225.0k -75.0k -75,000 -25.0%
70 ISHARES BITCOIN TRUST ETF SHS BEN INT IBIT IBIT 63,000 $3.9m0.39% 0.39% ReducedShares held: Q3 2024 250.0k, Q4 2024 275.0k, Q1 2025 110.0k, Q2 2025 63.0k -47.0k -47,000 -42.7%
71 IAMGOLD CORP COM IAG IAG 510,000 $3.7m0.38% 0.38% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 510.0k
72 TVARDI THERAPEUTICS INC COM TVRD TVRD 176,030 $3.6m0.37% 0.37% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 176.0k
73 NOBLE CORP PLC ORD SHS A NE NE 136,000 $3.6m0.37% 0.37% ReducedShares held: Q3 2024 167.1k, Q4 2024 262.1k, Q1 2025 215.0k, Q2 2025 136.0k -79.0k -79,000 -36.7%
74 SOLENO THERAPEUTICS INC COM SLNO SLNO 42,000 $3.5m0.36% 0.36% ReducedShares held: Q3 2024 51.3k, Q4 2024 50.0k, Q1 2025 50.0k, Q2 2025 42.0k -8.0k -8,000 -16.0%
75 HUDSON TECHNOLOGIES INC COM HDSN HDSN 375,000 $3.0m0.31% 0.31% ReducedShares held: Q3 2024 335.8k, Q4 2024 635.9k, Q1 2025 402.6k, Q2 2025 375.0k -27.6k -27,583 -6.8%
76 BRISTOW GROUP INC COM VTOL VTOL 88,133 $2.9m0.29% 0.29% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 88.1k
77 IMMATICS N.V SHS IMTX IMTX 540,000 $2.9m0.29% 0.29% ReducedShares held: Q3 2024 700.0k, Q4 2024 650.0k, Q1 2025 615.0k, Q2 2025 540.0k -75.0k -75,000 -12.2%
78 GLOBALSTAR INC COM NEW GSAT GSAT 123,000 $2.9m0.29% 0.29% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 131.0k, Q2 2025 123.0k -8.0k -8,012 -6.1%
79 WARRIOR MET COAL INC COM HCC HCC 61,000 $2.8m0.28% 0.28% ReducedShares held: Q3 2024 55.0k, Q4 2024 55.0k, Q1 2025 65.0k, Q2 2025 61.0k -4.0k -4,000 -6.2%
80 CARDLYTICS INC COM COM 1,650,000 $2.7m0.28% 0.28% AddedShares held: Q3 2024 2.2m, Q4 2024 1.3m, Q1 2025 1.6m, Q2 2025 1.6m +100.0k +100,000 6.5%
81 HOWARD HUGHES HOLDINGS INC COM HHH HHH 40,000 $2.7m0.27% 0.27% ReducedShares held: Q3 2024 135.0k, Q4 2024 135.0k, Q1 2025 120.0k, Q2 2025 40.0k -80.0k -80,000 -66.7%
82 NAVIGATOR HLDGS LTD SHS NVGS NVGS 190,000 $2.7m0.27% 0.27% UnchangedShares held: Q3 2024 0, Q4 2024 190.0k, Q1 2025 190.0k, Q2 2025 190.0k
83 PANGAEA LOGISTICS SOLUTION L SHS PANL PANL 565,000 $2.7m0.27% 0.27% ReducedShares held: Q3 2024 0, Q4 2024 607.1k, Q1 2025 610.0k, Q2 2025 565.0k -45.0k -44,990 -7.4%
84 DOUBLEDOWN INTERACTIVE CO LT ADS DDI DDI 275,000 $2.6m0.27% 0.27% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 275.0k
85 CARTESIAN THERAPEUTICS INC COM NEW RNAC RNAC 219,000 $2.3m0.23% 0.23% AddedShares held: Q3 2024 75.4k, Q4 2024 125.0k, Q1 2025 150.0k, Q2 2025 219.0k +69.0k +69,000 46.0%
86 INVIVYD INC COM IVVD IVVD 3,070,000 $2.2m0.22% 0.22% AddedShares held: Q3 2024 3.0m, Q4 2024 3.0m, Q1 2025 3.0m, Q2 2025 3.1m +70.0k +70,000 2.3%
87 INFLARX NV COM IFRX IFRX 2,475,000 $2.0m0.20% 0.20% ReducedShares held: Q3 2024 2.1m, Q4 2024 2.1m, Q1 2025 2.6m, Q2 2025 2.5m -150.0k -150,000 -5.7%
88 PHILIP MORRIS INTL INC COM PM PM 10,000 $1.8m0.18% 0.18% ReducedShares held: Q3 2024 160.0k, Q4 2024 160.0k, Q1 2025 160.0k, Q2 2025 10.0k -150.0k -150,000 -93.8%
89 MIRUM PHARMACEUTICALS INC NOTE 4.000% 5/0 · principal MIRM 4 05.01.29 · principal MIRM 4 05.01.29 1,000,000 $1.8m0.18% 0.18% UnchangedPrincipal held: Q3 2024 1.0m, Q4 2024 1.0m, Q1 2025 1.0m, Q2 2025 1.0m
90 VALARIS LTD CL A VAL VAL 37,500 $1.6m0.16% 0.16% ReducedShares held: Q3 2024 125.0k, Q4 2024 0, Q1 2025 40.0k, Q2 2025 37.5k -2.5k -2,500 -6.2%
91 BLUE WTR ACQUISITION CORP. I UNIT 05/23/2030 BLUWU BLUWU 150,000 $1.5m0.15% 0.15% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 150.0k
92 SILVERCORP METALS INC COM SVM SVM 350,000 $1.5m0.15% 0.15% ReducedShares held: Q3 2024 600.0k, Q4 2024 575.0k, Q1 2025 450.0k, Q2 2025 350.0k -100.0k -100,000 -22.2%
93 MODULAR MED INC COM NEW COM NEW 1,919,600 $1.4m0.15% 0.15% ReducedShares held: Q3 2024 1.5m, Q4 2024 1.6m, Q1 2025 2.0m, Q2 2025 1.9m -60.4k -60,400 -3.0%
94 HYLIION HOLDINGS CORP COMMON STOCK HYLN HYLN 850,000 $1.1m0.11% 0.11% ReducedShares held: Q3 2024 0, Q4 2024 350.0k, Q1 2025 950.0k, Q2 2025 850.0k -100.0k -100,000 -10.5%
95 THIRD HARMONIC BIO INC COM COM 200,000 $1.1m0.11% 0.11% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 200.0k, Q2 2025 200.0k
96 FRACTYL HEALTH INC COM COM 645,000 $1.0m0.11% 0.11% ReducedShares held: Q3 2024 625.0k, Q4 2024 650.0k, Q1 2025 650.0k, Q2 2025 645.0k -5.0k -5,000 -0.8%
97 LIGHTWAVE ACQUISITION CORP UNIT 06/06/2030 LWACU LWACU 100,000 $1.0m0.10% 0.10% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 100.0k
98 SHATTUCK LABS INC COM STTK STTK 1,095,000 $867.0k0.09% 0.09% AddedShares held: Q3 2024 0, Q4 2024 1.1m, Q1 2025 1.1m, Q2 2025 1.1m +45.0k +45,000 4.3%
99 OYSTER ENTERPRISES II ACQUIS UNIT 05/22/2030 OYSEU OYSEU 75,000 $759.0k0.08% 0.08% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 75.0k
100 IRSA INVERSIONES Y REP S A *W EXP 05/12/202 *W EXP 05/12/202 443,824 $745.6k0.08% 0.08% ReducedShares held: Q3 2024 4.8m, Q4 2024 5.1m, Q1 2025 3.6m, Q2 2025 443.8k -3.2m -3,193,350 -87.8%

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
INSMED INC INSM 0.75 06.01.28 INSM 0.75 06.01.28 15,428,000 $36.4m15.4m shares
ALLIANCEBERNSTEIN HLDG L P AB AB 525,825 $20.1m525.8k shares
HESS CORP HES HES 107,295 $17.1m107.3k shares
BAIDU INC BIDU BIDU 177,500 $16.3m177.5k shares
TG THERAPEUTICS INC TGTX TGTX 295,000 $11.6m295.0k shares
PDD HOLDINGS INC PDD PDD 95,000 $11.2m95.0k shares
ITEOS THERAPEUTICS INC ITOS ITOS 1,750,000 $10.4m1.8m shares
IOVANCE BIOTHERAPEUTICS INC IOVA IOVA 2,400,000 $8.0m2.4m shares
KBR INC KBR KBR 131,000 $6.5m131.0k shares
LEIDOS HOLDINGS INC LDOS LDOS 43,000 $5.8m43.0k shares
ADECOAGRO S A AGRO AGRO 474,103 $5.3m474.1k shares
TESLA INC TSLA TSLA 12,500 $3.2m12.5k shares
GALAPAGOS NV LKFT LKFT 110,100 $2.8m110.1k shares
ISHARES SILVER TR SLV SLV 75,000 $2.3m75.0k shares
SMARTRENT INC SMRT SMRT 1,350,000 $1.6m1.4m shares
DHT HOLDINGS INC DHT DHT 150,000 $1.6m150.0k shares
PONCE FINANCIAL GROUP INC PDLB PDLB 55,000 $696.9k55.0k shares
AFFIMED N V AFMDQ AFMDQ 654,600 $473.4k654.6k shares
METALLA RTY & STREAMING LTD MTA MTA 109,080 $315.4k109.1k shares
NUVATION BIO INC NUVB.WS NUVB.WS 335,754 $107.4k335.8k shares
GCT SEMICONDUCTOR HLDG INC GCTS GCTS 51,689 $84.8k51.7k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
PALANTIR TECHNOLOGIES INC PLTR · Put PLTRPut 685,200 $93.4m685.2k shares Added
TESLA INC TSLA · Put TSLAPut 288,000 $91.5m288.0k shares Reduced
ELI LILLY & CO LLY · Put LLYPut 105,000 $81.9m105.0k shares Reduced
MICROSTRATEGY INC MSTR · Put MSTRPut 144,800 $58.5m144.8k shares Reduced
ALNYLAM PHARMACEUTICALS INC ALNY · Put ALNYPut 141,300 $46.1m141.3k shares Added
MADRIGAL PHARMACEUTICALS INC MDGL · Put MDGLPut 152,000 $46.0m152.0k shares Unchanged
NOVO-NORDISK A S NVO · Put NVOPut 404,200 $27.9m404.2k shares Added
COINBASE GLOBAL INC COIN · Put COINPut 51,000 $17.9m51.0k shares Reduced
CAPITAL ONE FINL CORP COF · Put COFPut 75,000 $16.0m75.0k shares Reduced
HIMS & HERS HEALTH INC HIMS · Put HIMSPut 310,000 $15.5m310.0k shares Added
ASML HOLDING N V ASML · Put ASMLPut 15,000 $12.0m15.0k shares New
CITIGROUP INC C · Put CPut 100,000 $8.5m100.0k shares New
IONQ INC IONQ · Put IONQPut 155,000 $6.7m155.0k shares Added
LENNAR CORP LEN · Put LENPut 50,000 $5.5m50.0k shares Reduced
INSMED INC INSM · Put INSMPut 49,200 $5.0m49.2k shares New
PRAXIS PRECISION MEDICINES I PRAX · Put PRAXPut 74,300 $3.1m74.3k shares Reduced
UNIQURE NV QURE · Put QUREPut 37,500 $522.8k37.5k shares New
GOSSAMER BIO INC GOSS · Call GOSSCall 300,100 $369.1k300.1k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
GOSSAMER BIO INC GOSS · 13G · filed 2026-06-11 GOSS 10.0%≈ $8.2m +6.1 pts 13G 2026-06-11
MEREO BIOPHARMA GROUP PLC MREO · 13G · filed 2026-01-06 MREO 8.2% new 13G 2026-01-06
IN8BIO INC INAB · 13G · filed 2025-12-30 INAB 7.9%≈ $1.1m new 13G 2025-12-30
IMMUNIC INC 13G · filed 2026-02-17 5.9% -4.0 pts 13G 2026-02-17